Gianetti, Barbieri et al. [31] investigated pharmacological SGK1-inhibition in a variety of in vitro and ex vivo models of LQT1 and LQT2, including hiPSC-CMs and rabbit models. The gene discussed is SGK1; the disease is long QT syndrome 1.